Patents Represented by Law Firm Patent Department
  • Patent number: 8101743
    Abstract: Compounds, compositions and methods are provided for modulating the expression of transthyretin. The compositions comprise oligonucleotides, targeted to nucleic acid encoding transthyretin. Methods of using these compounds for modulation of transthyretin expression and for diagnosis and treatment of diseases and conditions associated with expression of transthyretin are provided.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: January 24, 2012
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Vickie L. Brown-Driver, Ravi Jain
  • Patent number: 8093689
    Abstract: A semiconductor sensor device is electrically coupled to an object. An attachment member attaches the semiconductor sensor device to the object. The attachment member comprises a first conductive contact region and a second conductive contact region. An insulating portion is electrically isolates the semiconductor sensor device from the first conductive contact region and second conductive contact region.
    Type: Grant
    Filed: July 2, 2007
    Date of Patent: January 10, 2012
    Assignee: Infineon Technologies AG
    Inventors: Wolfgang Stadler, Harald Gossner, Reinhold Gaertner
  • Patent number: 8084432
    Abstract: The present invention relates methods of treating pouchitis by administering a pharmaceutical formulation suitable for rectal use, such as an enema or suppository, comprising an antisense oligonucleotide targeted to ICAM-1 to an individual.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: December 27, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Mark K. Wedel, Philip P. Miner, Jr.
  • Patent number: 8081003
    Abstract: Implementations are presented herein that include a test circuit and a reference circuit.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: December 20, 2011
    Assignee: Infineon Technologies AG
    Inventors: Christian Pacha, Thomas Baumann, Georg Georgakos, Anselme Urlick Tchegho Kamgaing
  • Patent number: 8067386
    Abstract: Compounds, compositions and methods are provided for modulating the expression of eIF4E-BP2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding eIF4E-BP2. Methods of using these compounds for modulation of eIF4E-BP2 expression and for diagnosis and treatment of diseases and conditions associated with expression of eIF4E-BP2 are provided.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: November 29, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Sanjay Bhanot, Kenneth W. Dobie, Ravi Jain
  • Patent number: 7919612
    Abstract: Compositions comprising first and second oligomers are provided wherein at least a portion of the first oligomer is capable of hybridizing with at least a portion of the second oligomer, at least a portion of the first oligomer is complementary to and capable of hybridizing to a selected target nucleic acid, and at least one of the first or second oligomers includes a modified sugar and/or backbone modification. In some embodiments the modification is a 2? substituent group on a sugar moiety that is not H or OH. Oligomer/protein compositions are also provided comprising an oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex (RISC), wherein at least one nucleotide of the oligomer has a modified sugar and/or backbone modification.
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: April 5, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Brenda F. Baker, Anne B. Eldrup, Muthiah Manoharan, Balkrishen Bhat, Richard Griffey, Eric E. Swayze, Stanley T. Crooke, Thazha P. Prakash
  • Patent number: 7921148
    Abstract: A cell for an arithmetic logic unit includes a first input; a second input; a carry-in input; a first control input and a second control input; and a circuit connected to the first input, the second input, the carry-in input, the first control input, and the second control input. The circuit has a first output and a second output, the second output having a first value as a function of the first input and the second input when the first control input and the second control input are supplied values equal to a value at the carry-in input, and having a second value as a function of the first input and second input when the values at the first control input and the second control input are independent of the value at the carry-in input.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: April 5, 2011
    Assignee: Infineon Technologies AG
    Inventor: Thomas Kuenemund
  • Patent number: 7911039
    Abstract: A component arrangement comprising a carrier, a component in a housing with electrical contacts and a moulding compound that encloses the carrier, the semiconductor component in the housing and the electrical contacts, wherein the component is applied on the carrier, and wherein the carrier is provided with holes, and a method for producing a component arrangement, wherein the carrier is provided with holes, the component is positioned on the carrier, the component is connected to the carrier, the component with the carrier is positioned in the leadframe, and this arrangement is enclosed by a moulding compound.
    Type: Grant
    Filed: September 25, 2007
    Date of Patent: March 22, 2011
    Assignee: Infineon Technologies AG
    Inventors: Michael Bauer, Alfred Haimerl, Angela Kessler, Joachim Mahler, Wolfgang Schober
  • Patent number: 7884086
    Abstract: The present invention provides methods of identifying oligomeric compounds, such as siRNA and double-stranded RNA compounds, having bioactivity in vivo, and kits.
    Type: Grant
    Filed: September 7, 2005
    Date of Patent: February 8, 2011
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: C. Frank Bennett, Robert McKay, Brett P. Monia, Brenda F. Baker, Namir Sioufi
  • Patent number: 7868430
    Abstract: This application relates to a semiconductor device comprising multiple separate leads molded in a molded structure, and a chip attached to the molded structure over at least two of the multiple separate leads.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: January 11, 2011
    Assignee: Infineon Technologies AG
    Inventors: Stefan Paulus, Manfred Fries, Martin Petz, Thomas Mueller
  • Patent number: 7847375
    Abstract: This application relates to a semiconductor device, the semiconductor device comprising a metal carrier, an insulating foil partially covering the metal carrier, a first chip attached to the metal carrier over the insulating foil, and a second chip attached to the metal carrier over a region not covered by the insulating foil.
    Type: Grant
    Filed: August 5, 2008
    Date of Patent: December 7, 2010
    Assignee: Infineon Technologies AG
    Inventors: Joachim Mahler, Ralf Wombacher, Ralf Otremba
  • Patent number: 7825215
    Abstract: Compositions and methods are provided for the nucleic acid mimic determination of nucleic acids. The compositions and methods may be used in the diagnosis and treatment of diseases amenable through modulation of nucleic acids which encode proteins that are implicated in disease states. In accordance with preferred embodiments, mimics are comprised of non-naturally occurring backbones to which are appended modified heterocyclic bases. Such bases preferably have sterically bulky substituents 1, 2, or 3 atoms removed from the sites of attachment to the backbone.
    Type: Grant
    Filed: March 8, 1996
    Date of Patent: November 2, 2010
    Inventors: Leif Christensen, Henrik Frydenlund Hansen, Peter E. Nielsen
  • Patent number: 7812149
    Abstract: Compositions comprising first and second oligomers are provided wherein at least a portion of the first oligomer is capable of hybridizing with at least a portion of the second oligomer, at least a portion of the first oligomer is complementary to and capable of hybridizing to a selected target nucleic acid, and at least one of the first or second oligomers includes a modified sugar and/or backbone modification. In some embodiments the modification is a 2?-F substituent group on a sugar moiety. Oligomer/protein compositions are also provided comprising an oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex (RISC), wherein at least one nucleoside of the oligomer has a modified sugar and/or backbone modification.
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: October 12, 2010
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Thazha P. Prakash, Brenda F. Baker, Anne B. Eldrup, Muthiah Manoharan, Balkrishen Bhat, Richard Griffey, Eric E. Swayze, Stanley T. Crooke
  • Patent number: 7812373
    Abstract: A circuit array includes a plurality cells, wherein each cell has at least one group of odd fins. The cells may be arranged in a repeating pattern that includes mirror images of the pattern. A plurality of fin forming regions are provided about which the fins are formed for the dual fin and single fin transistors.
    Type: Grant
    Filed: February 12, 2007
    Date of Patent: October 12, 2010
    Assignee: Infineon Technologies AG
    Inventors: Florian Bauer, Klaus von Arnim
  • Patent number: 7790691
    Abstract: The present invention provides double stranded compositions that have a region that is complementary to a target nucleic acid. One of the targeting strand or the second strand comprises linked ribofuranosyl nucleosides and the other strand comprises linked modified nucleosides that have 3?-endo conformational geometry. The strands can be linked together or separate and may contain additional groups. The present invention also provides methods of using the compositions for modulating gene expression.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: September 7, 2010
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Bryan A. Kraynack, Brenda F. Baker, Balkrishen Bhat, Eric E. Swayze, Richard H. Griffey
  • Patent number: 7759480
    Abstract: A process of manufacturing oligonucleotides includes a 5?-deblocking step in which the 5-blocking group is removed with dichloroacetic acid that is essentially free of chloral. The process is useful for making oligonucleotides that are substantially free of chloral adducts.
    Type: Grant
    Filed: January 29, 2007
    Date of Patent: July 20, 2010
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Achim Krotz, Daniel C. Capaldi, Hans-Joachim Josef Gaus, Brett Turney
  • Patent number: 7723508
    Abstract: Compounds, compositions and methods are provided for modulating the expression of apolipoprotein(a). The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein(a). Methods of using these compounds for modulation of apolipoprotein(a) expression and for diagnosis and treatment of disease associated with expression of apolipoprotein(a) are provided.
    Type: Grant
    Filed: June 2, 2004
    Date of Patent: May 25, 2010
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Rosanne M. Crooke, Mark J. Graham
  • Patent number: 7723511
    Abstract: Methods for the formation of sulfurized oligonucleotides are provided. The methods allow for the formation of phosphorothioate linkages in the oligonucleotides or derivatives, without the need for complex solvent mixtures and repeated washing or solvent changes. Oligonucleotides having from about 8, and up to about 50, nucleotides can be sulfurized according to the methods of the invention with higher yields than have been previously reported.
    Type: Grant
    Filed: April 21, 2008
    Date of Patent: May 25, 2010
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Douglas L. Cole, Vasulinga Ravikumar, Zacharia S. Cheruvallath
  • Patent number: 7723777
    Abstract: One or more embodiments, relate to a field effect transistor, comprising: a substrate; a gate stack disposed over the substrate, the gate stack comprising a gate electrode overlying a gate dielectric; and a sidewall spacer may be disposed over the substrate and laterally disposed from the gate stack, the spacer comprising a polysilicon material.
    Type: Grant
    Filed: August 12, 2008
    Date of Patent: May 25, 2010
    Assignee: Infineon Technologies AG
    Inventors: John Power, Mayk Roehrich, Martin Stiftinger, Robert Strenz
  • Patent number: 7718810
    Abstract: Universal linkers, their facile processes of manufacture and methods of using the same are provided.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: May 18, 2010
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Vasulinga Ravikumar, Muthiah Manoharan, Andrei P. Guzaev, Zhiwei Wang, Raju K. Kumar